Daiichinkyo Co (FRA:D4S) Cyclically Adjusted Revenue per Share: €3.88 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:D4S Daiichi Sankyo Co Ltd FRA:D4S
80 GF Score
Price €14.72
GF Value €32.41
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Cyclically Adjusted Revenue per Share?

Daiichinkyo Co FRA:D4S -4.25% 80 Cyclically Adjusted Revenue per Share is €3.88 as of Mar. 2026. GuruFocus rates FRA:D4S with a GF Score™ of 80/100 and a GF Value™ of €32.41 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Daiichinkyo Co's adjusted revenue per share for the three months ended in Mar. 2026 was €1.736. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.88 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Daiichinkyo Co's average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Daiichinkyo Co was 11.00% per year. The lowest was 0.90% per year. And the median was 2.20% per year.

As of today (2026-07-23), Daiichinkyo Co's current stock price is €14.72. Daiichinkyo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €3.88. Daiichinkyo Co's Cyclically Adjusted PS Ratio of today is 3.79.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiichinkyo Co was 10.34. The lowest was 1.68. And the median was 5.36.


Daiichinkyo Co  (FRA:D4S) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Daiichinkyo Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=14.72/3.88
=3.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiichinkyo Co was 10.34. The lowest was 1.68. And the median was 5.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Daiichinkyo Co Cyclically Adjusted Revenue per Share Related Terms


Daiichinkyo Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Daiichinkyo Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co Cyclically Adjusted Revenue per Share Chart

Daiichinkyo Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 3.56 3.59 3.96 3.88

Daiichinkyo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.96 3.97 3.87 3.86 3.88

FRA:D4S vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted PS Ratio falls into.


FRA:D4S
80GF Score
Daiichi Sankyo Co Ltd FRA:D4S
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichinkyo Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.736/112.7000*112.7000
=1.736

Current CPI (Mar. 2026) = 112.7000.

Daiichinkyo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.991 98.100 1.138
201609 0.936 98.000 1.076
201612 1.130 98.400 1.294
201703 0.916 98.100 1.052
201706 0.962 98.500 1.101
201709 0.874 98.800 0.997
201712 1.022 99.400 1.159
201803 0.854 99.200 0.970
201806 0.901 99.200 1.024
201809 0.868 99.900 0.979
201812 1.031 99.700 1.165
201903 0.927 99.700 1.048
201906 1.048 99.800 1.183
201909 0.998 100.100 1.124
201912 1.175 100.500 1.318
202003 0.970 100.300 1.090
202006 1.004 99.900 1.133
202009 1.004 99.900 1.133
202012 1.053 99.300 1.195
202103 0.897 99.900 1.012
202106 1.038 99.500 1.176
202109 1.069 100.100 1.204
202112 1.139 100.100 1.282
202203 0.934 101.100 1.041
202206 1.032 101.800 1.142
202209 1.203 103.100 1.315
202212 1.242 104.100 1.345
202303 1.203 104.400 1.299
202306 1.194 105.200 1.279
202309 1.240 106.200 1.316
202312 1.484 106.800 1.566
202403 1.371 107.200 1.441
202406 1.340 108.200 1.396
202409 1.473 108.900 1.524
202412 1.581 110.700 1.610
202503 1.696 111.100 1.720
202506 1.533 111.700 1.547
202509 1.555 112.000 1.565
202512 1.651 113.000 1.647
202603 1.736 112.700 1.736

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €3.88 mean?
Daiichinkyo Co (FRA:D4S) has a Cyclically Adjusted Revenue per Share of €3.88 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Daiichinkyo Co and its competitors.
Is Daiichinkyo Co's Cyclically Adjusted Revenue per Share too high?
Daiichinkyo Co's current Cyclically Adjusted Revenue per Share is €3.88. Overall, Daiichinkyo Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Daiichinkyo Co's Cyclically Adjusted Revenue per Share of €3.88 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Daiichinkyo Co and its competitors. Daiichinkyo Co's current Cyclically Adjusted Revenue per Share is €3.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (FRA:D4S) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.41, compared to a current price of €14.72 — trading 54.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €3.88. Daiichinkyo Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Daiichinkyo Co (FRA:D4S), the current Cyclically Adjusted Revenue per Share is €3.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (FRA:D4S) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of €14.72 is trading 54.6% below its estimated GF Value™ of €32.41. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for FRA:D4S:

  • Cyclically Adjusted Revenue per Share: €3.88
  • GF Value™: €32.41 vs. price of €14.72 (54.6% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:D4S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
80GF Score

Get the complete analysis for FRA:D4S

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.72
Price
€32.41
GF Value